Junshi Biosciences Reports Q3 2024 Financials with Revenue Growth and Narrowed Losses
Junshi Biosciences (HKG: 1877; SHA: 688180) has released its financial results for the third quarter...
Chipsscreen Biosciences and Zhejiang Hisun Pharmaceutical End Strategic Partnership for Chiglitazar Launch
China-based Chipscreen Biosciences Co., Ltd (SHA: 688321) has reached an agreement with Zhejiang Hisun Pharmaceutical...
Eli Lilly Reports 20% YOY Revenue Growth in Q3 2024 Driven by Mounjaro and Zepbound
US pharmaceutical giant Eli Lilly and Company (NYSE: LLY) has reported its financial results for...
AstraZeneca China President Leon Wang Involved in Chinese Investigation Amid Industry Probes
Leon Wang, Executive Vice President International and AstraZeneca (AZ, NASDAQ: AZN) China President, is cooperating...
AbbVie’s Allergan Aesthetics Launches Juvéderm VOLUX in China
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced the official market launch of...
Jiangsu Yuyue Medical Equipment Partners with TÜV SUD to Boost Medical Device Market Access
Jiangsu Yuyue Medical Equipment Inc., (SHE: 002223), a Chinese medical equipment manufacturer, has entered into...
GSK Reports Mixed Q3 2024 Results with 2% YOY Revenue Growth
UK pharmaceutical giant GlaxoSmithKline (GSK; NYSE: GSK) has released its financial report for the third...
Allmed Medical Products to Establish Wholly Owned Subsidiary in Indonesia
China-based Allmed Medical Products Co., Ltd (SHE: 002950) has announced plans to establish a wholly...
Sichuan Kelun-Biotech’s Sacituzumab Tirumotecan Files for New Indication with China’s NMPA
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) has announced that the National Medical Products Administration...
Akeso Biopharma Initiates Phase III Clinical Trial for PD-1/VEGF Bispecific Antibody Combination
China-based Akeso Biopharma (HKG: 9926) has announced the enrollment of the first patient in a...
AbbVie Reports Q3 2024 Revenue Growth, Strength in Immunology and Neuroscience
US pharmaceutical company AbbVie (NYSE: ABBV) has announced its financial results for the third quarter...
Shanghai Henlius and Organon Submit Biosimilar Application for Denosumab to FDA
Shanghai Henlius Biotech Inc. (HKG: 2696) and its US partner Organon (NYSE: OGN) have jointly...
Pfizer Reports Strong Q3 Results, Boosts 2024 Guidance to $61-$64 Billion
Pfizer Inc. (NYSE: PFE) released its Q3 2024 financial results, reporting revenues of $17.702 billion...
AIM Vaccine Secures NMPA Approval for mRNA Vaccine Targeting RSV
AIM Vaccine Co., Ltd (HKG: 6660), based in China, has received clinical trial approval from...
Acotec Secures NMPA Approval for Acotrace Disposable Catheter Sheath
Acotec Scientific Holdings Ltd (HKG: 6669), based in China, has received marketing approval from the...
Innovent’s Fortvita Stake Sale Sparks Controversy, Shares Plummet Nearly 13%
Innovent Biologics, Inc. (HKG: 1801), headquartered in China, has announced a subscription agreement in which...
Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System
Sino Medical Sciences Technology Inc. (SHA: 688108), based in China, has announced the five-year follow-up...
Novartis Secures FDA Accelerated Approval for Scemblix in Newly Diagnosed CML Patients
Swiss pharmaceutical giant Novartis (NYSE: NVS) announced that its drug Scemblix (asciminib) has received accelerated...
MGI Tech Partners with OncoDNA to Enhance Precision Oncology Solutions
MGI Tech Co., Ltd., (SHA: 688114) a China-based leader in gene sequencing, announced a strategic...
Mindray Reports Q3 2024 Financials: International Revenues Surge Over 18% Amid Domestic Challenges
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760) reported its Q3 2024 financial results, revealing...